Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gsk Plc ADR (NY: GSK )

39.60 +0.70 (+1.80%)
Streaming Delayed Price Updated: 10:08 AM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gsk Plc ADR

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
29 30 Next >
GSK Shows Positive Pivotal Phase III Data For Its RSV Vaccine Candidate
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 6
Reuters 
Via Benzinga
FDA Approves GSK's Measles Vaccine
Via Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
GlaxoSmithKline: Dividend Insights
Wednesday marks the last chance for investors to receive the next dividend payout from GlaxoSmithKline (NYSE:GSK). 
Via Benzinga
Recap: GlaxoSmithKline Q1 Earnings
GlaxoSmithKline (NYSE:GSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Week In Review: Vivo Raises $600 Million In First Tranche Of China PE Fund
Vivo Capital held its first closing of a yuan-denominated private equity fund at $600 million, with a target of bringing the fund to $1.5 billion. Meanwhile, ProfoundBio closed a $70 million Series A+... 
Via Talk Markets
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
These biotech stocks face some key make-or-break events in June that could have big implication for their futures. 
Via InvestorPlace
3 Undervalued Dividend Growth Stocks
Investors who focus on a strategy of dividend growth stocks have performed better than some broader stock market indices. 
Via InvestorPlace
GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know
Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc. 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, June 1
Reuters Redbird Capital Buys Italian Football Club AC Milan 
Via Benzinga
Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off
Via Benzinga
3 Biotech Stocks to Buy Before They Boom
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations. 
Via InvestorPlace
Unilever Jumps After Nelson Peltz Joins Board
Unilever plc (NYSE: UL) shares traded higher by 8% on Tuesday after the company announced activist investor Nelson Peltz is joining the company's board of directors. 
Via Benzinga
GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck
The deal could vastly expand GlaxoSmithKline's vaccine offerings. 
Via Investor's Business Daily
Morning Brief: Top Financial Stories Dominating on Tuesday, May 31
CNBC Opportunities In Crypto Crash? Top Crypto Firms Hunt For Takeovers 
Via Benzinga
GSK To Scoop Clinical Stage US Biotech Affinivax For $3.3B To Shore Up Vaccine Business
Via Benzinga
Unilever To Add This Activist Investor To Board - What's The Catch?
Via Benzinga
Dow Up Nearly 300 Points, Eyeing Seventh-Straight Daily Win
An upbeat core personal consumption expenditures price index for April is boosting investor sentiment at midday after it showed slowing inflation. 
Via Talk Markets
GSK Turnaround Story
GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology. 
Via Talk Markets
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing. 
Via Talk Markets
HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty
Via Benzinga
Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others
Roche isn't the only company working on an anti-TIGIT molecule. 
Via Investor's Business Daily
Dividend Income Update April 2022
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated. 
Via Talk Markets
GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine
Via Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
GlaxoSmithKline's Earnings Outlook
GlaxoSmithKline (NYSE:GSK) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
Via Benzinga
The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.